Glucobrassicin, an indole glucosinolate widespread in cruciferous plants, appears to be involved in anticarcinogenic activity via its breakdown products. In order to study the “in vivo” metabolism of glucobrassicin, we have synthesized the 5‐[3H]‐indol‐3‐ylmethyl glucosinolate (3H‐labelled glucobrassicin) starting from artificial peracetylated 5‐bromoindol‐3‐ylmethyl glucosinolate. The labelled compounds were characterized by radio‐HPLC and FAB mass spectrometry.
No takes yet. Share an insight, caveat, or question.
Chevolleau et al. (1993) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: